Monday March 2, 2026
If there’s a theme emerging this week, it’s regulatory leverage and capital concentration — FDA decisions and nine-figure financings are separating positioned operators from the rest.
Also, a sincere thank you to the many readers who stepped up and gave after last week’s note about Afu Fiefia, the 19-year-old from Utah who recently lost his battle with Ewing Sarcoma. The response was extraordinary. In concert with your generosity, the family reached their financial goal — a powerful reminder that this community doesn’t just read, it shows up.
If you’d like to learn more about Afu, his life, or still contribute to the campaign, you can revisit last week’s newsletter here.
8 things to watch this week:
1. 💉 Abbott Wins FDA Approval for Updated Heart Failure Monitoring Device
Abbott secured FDA approval for its updated heart failure monitoring technology, reinforcing the strategic value of longitudinal patient data inside device ecosystems. For device leaders, this is another signal that remote monitoring + regulatory expansion is now a durable competitive moat.
MedTech Dive
2. 🧠 Radiology AI Firm Asks FDA to Exempt Certain Devices from Premarket Review
A radiology AI company is pushing for certain imaging tools to be exempt from FDA premarket review. If successful, this could meaningfully alter time-to-market assumptions for AI-enabled diagnostics — and shift capital allocation models across the imaging category.
Radiology Business
3. 💰 4DMedical Secures More Than $100M in Funding
4DMedical raised over $100M, underscoring investor appetite for advanced pulmonary imaging and functional lung diagnostics. Large rounds are increasingly consolidating category leaders early — raising the bar for competitors on both clinical validation and commercial scale.
MPO Magazine
4. 🔎 Commercial Strategy for Medical Device Leaders by RŌG Health
Medical device companies don’t struggle because they can’t build.
They struggle when commercialization, reimbursement, adoption, and capital strategy aren’t aligned.
RŌG Health helps device and medtech leaders pressure-test commercial readiness before major milestones — fundraising, FDA clearance, market expansion, or strategic partnerships.
We clarify the story, surface risk, and sharpen positioning — before execution capital is deployed. Strategic clarity for companies building in regulated markets.
5. 📊 Tandem Bests $1B in Worldwide Sales
Tandem Diabetes Care surpassed $1B in global sales — a major milestone in the insulin pump category. Scale in chronic disease management remains one of the most defensible revenue models in med device when product iteration and ecosystem integration are tight.
San Diego Business Journal
6. 💵 Salma Health Raises $80M Series A
Salma Health closed an $80M Series A, signaling continued investor confidence in care platform infrastructure plays. Even adjacent digital health models are now raising capital with stronger expectations around measurable outcomes and pathway integration.
Pulse 2.0
7. 🧪 Theradep and DSM-Firmenich Announce Strategic Partnership to Advance Next-Gen Bio-Surface Technologies
Theradep and DSM-Firmenich announced a strategic partnership to accelerate bio-surface technologies. Surface science continues to be an under-discussed differentiator in implantables and device durability — especially as infection prevention and material performance remain core hospital concerns.
Gainesville Press Release
8. 🏥 Daffodil Health Raises $16.3M Series A; Synchrony Medical Secures $5M Funding
Two funding rounds in care enablement and medical technology signal continued activity in early-stage health IT and device infrastructure. Capital is flowing — but increasingly toward companies with clearer clinical integration strategies.
Healthcare IT Today
🧭 About The Pathway
The Pathway is a curated briefing for medical device leaders, focused on regulatory moves, product launches, partnerships, and market signals shaping the industry.
If this was useful, consider subscribing or sharing with a colleague who should be tracking these developments.
Want to put your brand in front of 35,000+ medical device and med tech leaders each week? Contact us to learn more about sponsorship opportunities.
Some issues may include sponsored or partner content. Sponsorship does not influence editorial selection of third-party news items.